Oelegem Pharma SPRL

2.3 FTE

Oelegem Pharma reported total assets of €1.84m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026), with 2.3 full-time equivalents.

By total assets for 2025, Oelegem Pharma ranks among the 500 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0538.973.372 · VAT BE0538973372
2520 Ranst
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 25 Sep 2013 (≈ 13 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Oelegem Pharma shows with a free account.

See the score
Profile
SPRL Micro · 2.3 FTE since 2013
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result237,016 €
Equity351,847 €
Cash224,759 €
EBITDA350,132 €
Total assets€1.84m
Headcount (avg FTE)2.3
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +88 % Total assets +193 % Headcount (avg FTE) +10 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Oelegem Pharma's annual accounts

20252024202320222021
Net result237,016 €
Equity351,847 €
Cash224,759 €
EBITDA350,132 €
Total assets€1.84m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 24 Aug 2026
  • Year ended 31 Dec 2024filed on 20 Aug 2025
  • Year ended 31 Dec 2023filed on 05 Aug 2024
  • Year ended 31 Dec 2022filed on 25 Jul 2023
  • Year ended 31 Dec 2021filed on 27 Jul 2022

Oelegem Pharma's financial analysis

Management and control of Oelegem Pharma

2 active director(s) in the register.

Oelegem Pharma's shareholders and holdings →

Oelegem Pharma's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0538.973.372
VAT number
BE0538973372
Peppol
Registered · 0208:0538973372 · as of 10 Nov 2026
Legal form
SPRL
Incorporated
25 Sep 2013
Registered office
2520 Ranst
Size
Micro · 2.3 FTE
Latest accounts
2025 · filed on 24 Aug 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Oelegem Pharma (SPRL) has been based in Ranst since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 237,016 € and equity of 351,847 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 19.1%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Oelegem Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Oelegem Pharma

What is the revenue of Oelegem Pharma?

Oelegem Pharma files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Oelegem Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0538973372 for Oelegem Pharma, if the company is VAT-registered. Its company number (CBE) is 0538.973.372.

Where is the registered office of Oelegem Pharma?

According to the CBE register, the registered office of Oelegem Pharma is in 2520 Ranst.

What is the equity of Oelegem Pharma?

At the close of the 2025 financial year, the equity of Oelegem Pharma amounts to 351,847 €, a solvency of 19.1% of total assets.

How many people work at Oelegem Pharma?

2.3 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Oelegem Pharma?

The register lists 2 active mandates at Oelegem Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Oelegem Pharma within its sector?

By total assets for 2025, Oelegem Pharma ranks among the 500 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.

Idonis

The full file of Oelegem Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 25 Aug 2026

No credit card, no commitment.

What each plan unlocks →